Business
CardioComm Announces Adoption of Quarterly Reporting Exemption Under Coordinated Blanket Order 51-933
Toronto, Ontario--(Newsfile Corp. - May 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leader in consumer heart monitoring, remote patient monitoring, and medical electrocardiogram ("ECG") software solutions, announces that it has elected to rely on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers and move to semi-annual financial reporting ("SAR"). Coordinated Blanket Order 51-933 allows eligible...
About this update from Cardiocomm Solutions, Inc.
[{"type":"text","content":"Toronto, Ontario--(Newsfile Corp. - May 8, 2026) - CardioComm Solutions, Inc. (TSXV: EKG) ("CardioComm" or the "Company"), a leader in consumer heart monitoring, remote patient monitoring, and medical electrocardiogram ("ECG") software solutions, announces that it has elected to rely on Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers and move to semi-annual financial reporting ("SAR").","length":484,"tagName":"p"},{"type":"text","content":"Coordinated Blanket Order 51-933 allows eligible venture issuers listed on the TSX Venture Exchange (the "TSXV") to voluntarily move from a quarterly to a semi-annual financial reporting framework. The Company's fiscal year ends on December 31. Under the SAR pilot program:","length":287,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Interim Period: The Company will be exempt from filing an interim financial report and related Management's Discussion & Analysis for the first quarter (Q1) ended March 31, 2026 and the third quarter (Q3) ending September 30, 2026; and","length":243,"tagName":"p","attribs":{}}]},{"val":[{"type":"text","content":"Ongoing Reporting: CardioComm will continue to file audited annual financial statements (due within 120 days of December 31, 2026) and six-month interim financial reports (due within 60 days of June 30, 2026).","length":209,"tagName":"p","attribs":{}}]}],"tagName":"ul","bulletedList":true,"length":452,"olType":false},{"type":"text","content":"The Company confirms it meets the SAR pilot program's eligibility criteria, which include being a venture issuer with annual revenues of less than $10 million as shown on its most recently filed audited annual financial statements, having been a reporting issuer in at least one jurisdiction of Canada for 12 months or more, and having filed all required periodic and timely disclosure documents under applicable Canadian securities legislation.","length":449,"tagName":"p"},{"type":"text","content":"This news release is being filed pursuant to Coordinated Blanket Order 51-933 Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers.","length":149,"tagName":"p"},{"type":"text","content":"About CardioComm Solutions, Inc.","length":32,"tagName":"p"},{"type":"text","c...